Evidence map›Paper›PMID 42500526›Full record

ReviewFrontiers in medicine2026

The evolving landscape of minimally invasive procedures in musculoskeletal diseases-part I.

Fernando Saraiva, Esperanza Naredo

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fernando SaraivaServiço de Reumatologia e Doenças Ósseas Metabólicas, Unidade Local de Saúde de Santa Maria, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
Esperanza NaredoServiço de Reumatologia e Doenças Ósseas Metabólicas, Unidade Local de Saúde de Santa Maria, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review aims to cover a wide array of minimally invasive musculoskeletal procedures developed to address several articular and periarticular conditions locally. Besides details related to ultrasound guidance, in part 1, we will review barbotage, botulinum toxin, corticosteroids, dry needling, gene therapy, hyaluronic acid, hydrodissection and mesenchymal stem cells. In part II, we will cover nerve blocks, ozonetherapy, platelet-rich plasma and derivatives, prolotherapy, radiopharmaceuticals, sclerotherapy, thermal ablation and intratissue percutaneous electrolysis. A review of guidelines covering these issues will also be presented.

Indexed as

botulinum toxincorticosteroidsgene therapyhyaluronic acidhydrodissectionminimally invasive musculoskeletal proceduresplatelet-rich plasmaultrasound guidance

Identifiers

PMID42500526
PMCPMC13396120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.